Allergan plc Overview
Pro stress-test →Allergan is a developer and manufacturer of a portfolio of generic medicines focused on various therapeutic categories, including dermatology and aesthetics, CNS, eye care, women's health, urology, GI and cystic fibrosis, cardiovascular, and infectious disease. As a publicly traded pharmaceutical company on the NYSE, Allergan serves a diverse global patient base across multiple treatment areas.
Strategic Profile
Pro stress-test →As of March 31, 2026, Allergan employs 10,043 people. The company operates across broad therapeutic segments with established commercial operations in key markets. Allergan's diversified portfolio spans both specialty and generic pharmaceutical offerings.
Competitive Landscape
Pro stress-test →Allergan competes within the diversified pharmaceutical landscape against both branded and generic manufacturers including Teva, Mylan, Sun Pharmaceutical, and branded leaders like Pfizer, Johnson & Johnson, and AbbVie, particularly in aesthetics, CNS, and ophthalmology segments where brand recognition and market access are critical.
Industry Context
Allergan plc operates in Pharmaceutical Manufacturing & Generic Medicines.
Key facts
Founded: 1950 · Headquarters: Dublin, Ireland · Employees: 10,043 · Revenue: $5.8B (2013) · Market cap: N/A